reported minimal QoL variations and improvements in baseline GHS, whereas our study identified a temporary decline in GHS at 3 months with an increasing trend at 6 and 12 months.
← all excerpts
Clinical outcomes and quality of life in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac in an Australian setting.
1
—
—